L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes
- PMID: 15322107
- DOI: 10.1074/jbc.M406146200
L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes
Abstract
Hyaluronidases are enzymes that degrade hyaluronan, an important component of the extracellular matrix. The mammalian hyaluronidases are considered to be involved in many (patho)physiological processes like fertilization, tumor growth, and metastasis. Bacterial hyaluronidases, also termed hyaluronate lyases, contribute to the spreading of microorganisms in tissues. Such roles for hyaluronidases suggest that inhibitors could be useful pharmacological tools. Potent and selective inhibitors are not known to date, although L-ascorbic acid has been reported to be a weak inhibitor of Streptococcus pneumoniae hyaluronate lyase (SpnHL). The x-ray structure of SpnHL complexed with L-ascorbic acid has been elucidated suggesting that additional hydrophobic interactions might increase inhibitory activity. Here we show that L-ascorbic acid 6-hexadecanoate (Vcpal) is a potent inhibitor of both streptococcal and bovine testicular hyaluronidase (BTH). Vcpal showed strong inhibition of Streptococcus agalactiae hyaluronate lyase with an IC(50) of 4 microM and weaker inhibition of SpnHL and BTH with IC(50) values of 100 and 56 microM, respectively. To date, Vcpal has proved to be one of the most potent inhibitors of hyaluronidase. We also determined the x-ray structure of the SpnHL-Vcpal complex and confirmed the hypothesis that additional hydrophobic interactions with Phe-343, His-399, and Thr-400 in the active site led to increased inhibition. A homology structural model of BTH was also generated to suggest binding modes of Vcpal to this hyaluronidase. The long alkyl chain seemed to interact with an extended, hydrophobic channel formed by mostly conserved amino acids Ala-84, Leu-91, Tyr-93, Tyr-220, and Leu-344 in BTH.
Similar articles
-
Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases.Bioorg Med Chem Lett. 2006 Oct 15;16(20):5313-6. doi: 10.1016/j.bmcl.2006.07.087. Bioorg Med Chem Lett. 2006. PMID: 16908142
-
Sulphated oligosaccharides as inhibitors of hyaluronidases from bovine testis, bee venom and Streptococcus agalactiae.Planta Med. 2005 Aug;71(8):727-32. doi: 10.1055/s-2005-871255. Planta Med. 2005. PMID: 16142636
-
New potent indole derivatives as hyaluronidase inhibitors.Chem Biol Drug Des. 2007 Dec;70(6):547-51. doi: 10.1111/j.1747-0285.2007.00590.x. Epub 2007 Nov 6. Chem Biol Drug Des. 2007. PMID: 17986205
-
Hyaluronidases and hyaluronate lyases: From humans to bacteriophages.Colloids Surf B Biointerfaces. 2021 Dec;208:112095. doi: 10.1016/j.colsurfb.2021.112095. Epub 2021 Sep 2. Colloids Surf B Biointerfaces. 2021. PMID: 34507069 Review.
-
Inhibitors of the hyaluronidases.Matrix Biol. 2002 Jan;21(1):31-7. doi: 10.1016/s0945-053x(01)00185-8. Matrix Biol. 2002. PMID: 11827790 Review.
Cited by
-
A modified flavonoid accelerates oligodendrocyte maturation and functional remyelination.Glia. 2020 Feb;68(2):263-279. doi: 10.1002/glia.23715. Epub 2019 Sep 6. Glia. 2020. PMID: 31490574 Free PMC article.
-
Vitamin C-squalene bioconjugate promotes epidermal thickening and collagen production in human skin.Sci Rep. 2020 Oct 9;10(1):16883. doi: 10.1038/s41598-020-72704-1. Sci Rep. 2020. PMID: 33037252 Free PMC article.
-
A novel hyaluronidase from brown spider (Loxosceles intermedia) venom (Dietrich's Hyaluronidase): from cloning to functional characterization.PLoS Negl Trop Dis. 2013 May 2;7(5):e2206. doi: 10.1371/journal.pntd.0002206. Print 2013. PLoS Negl Trop Dis. 2013. PMID: 23658852 Free PMC article.
-
Mycobacteria exploit host hyaluronan for efficient extracellular replication.PLoS Pathog. 2009 Oct;5(10):e1000643. doi: 10.1371/journal.ppat.1000643. Epub 2009 Oct 30. PLoS Pathog. 2009. PMID: 19876387 Free PMC article.
-
A TLR/AKT/FoxO3 immune tolerance-like pathway disrupts the repair capacity of oligodendrocyte progenitors.J Clin Invest. 2018 May 1;128(5):2025-2041. doi: 10.1172/JCI94158. Epub 2018 Apr 16. J Clin Invest. 2018. PMID: 29664021 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical